Company Search:
Advanced Search
Sponsored Links
Clovis Oncology Inc Company Snapshot
Clovis Oncology Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clovis Oncology Inc with three other companies in this sector in the United States: Endocyte, Inc. (2016 sales of $70,000.00 ), RegeneRx Biopharmaceuticals, Inc. ($93,308.00 ), and Cara Therapeutics Inc ($86,000.00 of which 100% was Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Clovis Oncology Inc
  Stock Performance Chart for Clovis Oncology Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 63.21
(Figures in U.S. Dollars)
1 Week -5.6%   13 Weeks -18.4%  
4 Weeks -12.2%   52 Weeks 76.9%  
Clovis Oncology Inc Key Data:
  Ticker: CLVS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 78,000
(Year Ending Jan 2017).
Employees: 278
  Currency: U.S. Dollars Market Cap: 3,097,446,002
  Fiscal Yr Ends: December Shares Outstanding: 49,002,468
  Share Type: Common Closely Held Shares: 1,564,474
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.